Skip Navigation

An Open-Label Expanded Access Program Of Futibatinib TAS-120 In Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements

Brief Summary

Type:
Gastrointestinal - Other

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT04507503

Study #:
STUDY00146520

Start Date:
Feb 11, 2021

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04507503

View Complete Trial Details & Eligibility at ClinicalTrials.gov